VILMA BOHLMANN: Open Payments
NPI 1629340229 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 62 payments from 7 companies in 2025. Trend: 2023 $827 · 2024 $1,133 · 2025 $1,140
Food & beverage: $1,140
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 45 | $780 |
| ABBVIE INC. | 11 | $142 |
| Calyxo, Inc. | 2 | $123 |
| Dendreon Pharmaceuticals LLC | 1 | $31 |
| UROGEN PHARMA, INC. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Medtronic, Inc. | 1 | $14 |
Products named: GEMTESA, BOTOX, CVAC ASPIRATION SYSTEM, PROVENGE, ORGOVYX, PLUVICTO, INTERSTIM, LUPRON DEPOT.
Industry payments across TX — which companies pay providers there.
